Bibliography
- Camu F, Van Aken H, Bovill JG. Postoperative analgesic effects of three demand-dose sizes of fentanyl administered by patient-controlled analgesia. Anesth Analg 1998;4:890–5
- Sathyan G, Jaskowiak J, Evashenk M, Gupta S. Characterisation of the pharmacokinetics of the fentanyl HCl patient-controlled transdermal system (PCTS): effect of current magnitude and multiple-day dosing and comparison with IV fentanyl administration. Clin Pharmacokinet 2005;44(Suppl 1):7–15
- Gupta SK, Bernstein KJ, Noorduin H, et al. Fentanyl delivery from an electrotransport system: delivery is a function of total current, not duration of current. J Clin Pharmacol 1998;38:951–8
- Gupta SK, Southam M, Sathyan G, Klausner M. Effect of current density on pharmacokinetics following continuous or intermittent input from a fentanyl electrotransport system. J Pharm Sci 1998;8:976–81
- Gupta SK, Sathyan G, Phipps B, et al. Reproducible fentanyl doses delivered intermittently at different time intervals from an electrotransport system. J Pharm Sci 1999;8:835–41
- Gupta SK, Hwang S, Southam M, Sathyan G. Effects of application site and subject demographics on the pharmacokinetics of fentanyl HCl patient-controlled transdermal system (PCTS). Clin Pharmacokinet 2005;44(Suppl 1):25–32
- Sathyan G, Phipps B, Gupta SK. Passive absorption of fentanyl from the fentanyl HCl iontophoretic transdermal system. Curr Med Res Opin 2009;2:363–6
- Phipps JB, Padmanabhan RV, Young W, et al. E-TRANS technology. In: Rathbone MJ, Hadgraft MS, Roberts MS, editors. Modified-release drug delivery technology. Marcel Dekker, Inc; New York: 2002. p. 499–511
- Chelly JE, Grass J, Houseman TW, et al. The safety and efficacy of a fentanyl patient-controlled transdermal system for acute postoperative analgesia: a multicenter, placebo-controlled trial. Anesth Analg 2004;2:427–33; table of contents
- Grond S, Hall J, Spacek A, et al. Iontophoretic transdermal system using fentanyl compared with patient-controlled intravenous analgesia using morphine for postoperative pain management. Br J Anaesth 2007;6:806–15
- Hartrick CT, Bourne MH, Gargiulo K, et al. Fentanyl iontophoretic transdermal system for acute-pain management after orthopedic surgery: a comparative study with morphine intravenous patient-controlled analgesia. Reg Anesth Pain Med 2006;6:546–54
- Minkowitz HS, Rathmell JP, Vallow S, et al. Efficacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery. Pain Med 2007;8:657–68
- Viscusi ER, Reynolds L, Chung F, et al. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. JAMA 2004;11:1333–41
- Viscusi ER, Reynolds L, Tait S, et al. An iontophoretic fentanyl patient-activated analgesic delivery system for postoperative pain: a double-blind, placebo-controlled trial. Anesth Analg 2006;1:188–94
- US Department of Health and Human Services. Guidance for industry: statistical approaches to establishing bioequivalence. Available from: http://www.fda.gov/downloads/Drugs/Guidances/ucm070244.pdf [Last accessed 30 July 2014]